Format

Send to

Choose Destination
Lancet Oncol. 2010 Sep;11(9):880-9. doi: 10.1016/S1470-2045(09)70369-9. Epub 2010 May 7.

Genetic aberrations in paediatric acute leukaemias and implications for management of patients.

Author information

1
Department of Pediatric Haematology and Oncology, Medical University of Silesia, Zabrze, Poland. szczep57@poczta.onet.pl

Abstract

The process of malignant transformation in paediatric acute leukaemias is complex, requiring at least two deleterious events resulting in DNA damage. This damage ranges from point-mutations to double-strand DNA breaks leading to various types of chromosomal rearrangements. In this review we summarise the most common genetic aberrations for the three main subtypes of paediatric acute leukaemia: B-cell-precursor acute lymphoblastic leukaemia, T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Several genetic aberrations are independent prognostic factors, and are now used in risk stratification for treatment. Molecular pathways activated by genetic aberrations could provide potential molecular targets for novel therapies. Some genetic aberrations represent sensitive targets for molecular detection of minimal residual disease. This provides hope for the development of targeted therapies, effective against leukaemic cells.

PMID:
20435517
DOI:
10.1016/S1470-2045(09)70369-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center